A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen
Phase of Trial: Phase III
Latest Information Update: 07 Apr 2011
At a glance
- Drugs Entecavir; Lamivudine
- Indications Hepatitis B
- Focus Therapeutic Use
- 07 Apr 2011 Last checked against ClinicalTrials.gov record.
- 02 Oct 2010 Results will be presented at the 61st annual meeting of the American Association for the Study of Liver Diseases (AASLD), according to a Bristol-Myers Squibb media release.
- 30 Nov 2009 2-year results were published in the Journal of Viral Hepatitis.